We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
FUJIFILM Irvine Scientific Expands its Armstrong R&D Cell Culture Center of Excellence to Accelerate New Product Development and Broaden Service Offerings
SANTA ANA, California, November 10, 2021: FUJIFILM Irvine Scientific, Inc., a world leader in providing cell culture solutions for Life Science and Medical markets, today announced the expansion of its Armstrong R&D Center of Excellence at its headquarters in California. This expansion marks an ongoing commitment to the advancement of discovery research, bioproduction, cell and gene therapy, assisted reproductive technologies and cytogenetics in its Life Sciences and Medical Media divisions. Leveraging a deep understanding of cell biology and cell culture solutions, FUJIFILM Irvine Scientific continues to expand its diverse offering of specialty media, technologies, and custom media services.
"With society’s increasing demand for global access to more high-quality, cost-effective vaccines, biopharmaceuticals, cell-based therapies, gene therapies, and in-vitro fertilization procedures, the need for a broadened focus on innovation is pivotal to expedite critical product and technology development. The expansion project will more than double the R&D facility's footprint and will allow for more enhanced technical collaboration between R&D experts and customers to develop personalized solutions and enhance partnership opportunities." said Bob Newman, chief scientific officer, FUJIFILM Irvine Scientific.
With significant sales growth in the past year, and new manufacturing capabilities in Europe, this expansion will be essential to the success of new programs and initiatives FUJIFILM Irvine Scientific offers, including Manufacturing Sciences and Technologies (MSAT), Single-Use technology development, and automation platforms for media development. The expanded footprint will also include dedicated space for analytical chemistry, virology, Assisted Reproductive Technology (ART), and additional cell culture and molecular-based assay development, increasing employment opportunities and projecting a doubling of growth in R&D headcount by the close of 2022.
The construction began in October and is planned for completion by January, 2022.
Notes to Editors
FUJIFILM Irvine Scientific
FUJIFILM Irvine Scientific, Inc., is a worldwide leader in the innovation and manufacture of cell culture media, reagents, and medical devices for researchers and clinicians. The company provides unrivaled service and quality to scientists working in biopharmaceuticals, cell therapy, and regenerative medicine, assisted reproductive technology and cytogenetics, and industrial cell culture for the large-scale production of biotherapeutics and vaccines. FUJIFILM Irvine Scientific adheres to both ISO and FDA regulations and operates dual cGMP manufacturing facilities in California, USA, and Tokyo, Japan. The company’s consultative philosophy combined with expertise in cell culture and compliance provides customers with unique capabilities and support. For over 50 years, FUJIFILM Irvine Scientific has remained uniquely flexible and focused on media while becoming a strategic global leader in media products and services. FUJIFILM Irvine Scientific, Inc. is a subsidiary of FUJIFILM Holdings America Corporation reporting to FUJIFILM Holdings Corporation.
FUJIFILM Holdings
FUJIFILM Holdings Corporation, Tokyo, Japan, brings cutting edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to the various fields including healthcare, highly functional materials, document solutions and imaging products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the year ended March 31, 2021, the company had global revenues of $21 billion, at an exchange rate of 106 yen to the dollar. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.
Media Contacts
Lori Serles
FUJIFILM Irvine Scientific
Phone: (949) 261-7800 x145
Email: lori.serles@fujifilm.com
Lorna Cuddon
Zyme Communications
Phone: +44 (0)7811 996 942
Email: lorna.cuddon@zymecommunications.com